Ampio Pharmaceuticals Inc. (AMPE)

0.54
0.03 5.98
AMEX : Health Technology
Prev Close 0.58
Open 0.56
Day Low/High 0.53 / 0.59
52 Wk Low/High 0.35 / 4.95
Volume 521.05K
Avg Volume 1.66M
Exchange AMEX
Shares Outstanding 106.72M
Market Cap 61.60M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc.

Ampio Provides Corporate Update

Ampio Provides Corporate Update

ENGLEWOOD, Colo., Oct.

AMPE ALERT: Rosen Law Firm Files First Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc.; Important Deadline - AMPE

AMPE ALERT: Rosen Law Firm Files First Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc.; Important Deadline - AMPE

NEW YORK, Sept. 22, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Ampio Pharmaceuticals, Inc.

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ampio Pharmaceuticals, Inc.

Glancy Prongay & Murray LLP Announces The Filing Of A Securities Class Action On Behalf Of Ampio Pharmaceuticals, Inc. Investors (AMPE)

Glancy Prongay & Murray LLP Announces The Filing Of A Securities Class Action On Behalf Of Ampio Pharmaceuticals, Inc. Investors (AMPE)

Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit has been filed on behalf of investors that purchased or otherwise acquired securities of Ampio Pharmaceuticals, Inc.

First Week Of AMPE January 2021 Options Trading

First Week Of AMPE January 2021 Options Trading

Investors in Ampio Pharmaceuticals Inc saw new options begin trading this week, for the January 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 850 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Ampio Pharmaceuticals, Inc. Of Class Action Lawsuit And Upcoming Deadline - AMPE

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Ampio Pharmaceuticals, Inc. Of Class Action Lawsuit And Upcoming Deadline - AMPE

NEW YORK, Sept. 17, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ampio Pharmaceuticals, Inc.

Lifshitz & Miller LLP Announces Investigation Of Ampio Pharmaceuticals, CV Sciences, Inc., Facebook, Inc., Farmland Partners Inc., LogMeIn, Inc., Nevro Corporation, Sinclair Broadcast Group, Inc. And Tribune Media Company

Lifshitz & Miller LLP Announces Investigation Of Ampio Pharmaceuticals, CV Sciences, Inc., Facebook, Inc., Farmland Partners Inc., LogMeIn, Inc., Nevro Corporation, Sinclair Broadcast Group, Inc. And Tribune Media Company

NEW YORK, Sept. 12, 2018 /PRNewswire/ -- Ampio Pharmaceuticals (AMPE) Lifshitz & Miller announces investigation into possible securities laws violations in connection with the effectiveness and adequacy of Ampio's AP-003-A and AP-003-C trials.

Dr. David Bar-Or Retires As Chief Scientific Officer Of Ampio Pharmaceuticals

Dr. David Bar-Or Retires As Chief Scientific Officer Of Ampio Pharmaceuticals

Retains Board of Director and Scientific Advisory Board positions

AMPE LOSS NOTICE: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors Of Important Deadline In First Filed Case Commenced By Firm - AMPE

AMPE LOSS NOTICE: Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors Of Important Deadline In First Filed Case Commenced By Firm - AMPE

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc.

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ampio Pharmaceuticals, Inc. To Contact The Firm

NEW YORK, Aug. 27, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ampio Pharmaceuticals, Inc.

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against Ampio Pharmaceuticals, Inc. (AMPE) And Lead Plaintiff Deadline - October 24, 2018

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against Ampio Pharmaceuticals, Inc. (AMPE) And Lead Plaintiff Deadline - October 24, 2018

NEW YORK, Aug. 27, 2018 /PRNewswire/ -- Attorney Advertising --Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ampio Pharmaceuticals, Inc.

Ampio Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. - AMPE

Ampio Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. - AMPE

NEW YORK, Aug. 26, 2018 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Ampio...

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. - AMPE

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. - AMPE

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Ampio Pharmaceuticals, Inc.

AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm

AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ampio Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Ampio Pharmaceuticals, Inc. (AMPE)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Ampio Pharmaceuticals, Inc. (AMPE)

NEW YORK, Aug. 10, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ampio Pharmaceuticals, Inc.

AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm

AMPIO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Ampio Pharmaceuticals, Inc. To Contact The Firm

NEW YORK, Aug. 9, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ampio Pharmaceuticals, Inc.

Investor Alert: Kaplan Fox Announces Investigation Of Ampio Pharmaceuticals, Inc.

Investor Alert: Kaplan Fox Announces Investigation Of Ampio Pharmaceuticals, Inc.

NEW YORK, Aug. 8, 2018 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP ( www.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Ampio Pharmaceuticals, Inc. - AMPE

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Ampio Pharmaceuticals, Inc. - AMPE

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Ampio Pharmaceuticals, Inc.

AMPE Alert: Bernstein Liebhard LLP Announces Investigation Of Ampio Pharmaceuticals, Inc. - AMPE

AMPE Alert: Bernstein Liebhard LLP Announces Investigation Of Ampio Pharmaceuticals, Inc. - AMPE

NEW YORK, Aug. 8, 2018 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc. To Present At The 38th Annual Canaccord Genuity Growth Conference

Ampio Pharmaceuticals, Inc. To Present At The 38th Annual Canaccord Genuity Growth Conference

ENGLEWOOD, Colo., August 2, 2018 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

Ampio Provides A Link To New Publication On The Mechanism Of Action For Ampion™

Ampio Provides A Link To New Publication On The Mechanism Of Action For Ampion™

ENGLEWOOD, Colo., July 12, 2018 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.

Ampio Reports New Publication On The Mechanisms Of Action For Ampion™

Ampio Reports New Publication On The Mechanisms Of Action For Ampion™

ENGLEWOOD, Colo., June 27, 2018 /PRNewswire/ --  Ampio Pharmaceuticals, Inc.